India's direct-to-consumer startups have demonstrated remarkable growth in equity funding over the past five years, raising nearly $6 billion across nearly 2,000 rounds between 2021 and 2026 year-to-date. According to Tracxn's latest India D2C Report, this funding was distributed across various stages of company development, with the sector showing significant maturation in funding patterns and investment preferences. The report reveals that 15 D2C IPOs were recorded between 2021 and 2026 YTD, alongside 105 acquisitions by established consumer conglomerates, marking a significant shift in the exit landscape. The top five active funded companies have raised a combined $2.3 billion across their lifetimes, spanning four consumption categories - eyewear, meat and seafood, jewellery, and dairy.
The funding landscape has followed a clear cycle over the past five years, with 2022 marking the peak at $1.6 billion in annual funding. As reported by Tracxn's analysis, funding moderated to $824 million by 2024 before returning to growth in 2025 at $898 million, representing a 9% year-on-year increase. What stayed constant throughout was deal-making pace: every full year in the window recorded between 307 and 380 rounds, with 2024 posting the window's highest round count in the very year funding value hit its lowest point. However, 2026 YTD funding has dropped significantly to $398 million, representing the lowest annual funding level in the five-year period.
The D2C sector has witnessed significant public market activity with 15 D2C IPOs recorded between 2021 and 2026 YTD. Among the most notable, Lenskart listed on November 10, 2025 backed by dozens of institutional investors, including SoftBank Vision Fund, Temasek, KKR, and ADIA, after raising $981 million privately, representing the largest funding base of any company in this report. BlueStone listed on August 19, 2025 after raising $255 million, and Wakefit listed on December 15, 2025 after raising $105 million across multiple institutional investors. Honasa Consumer, the parent of Mamaearth, listed on November 7, 2023 after raising $126 million, one of the earliest and most closely watched D2C listings in India. Credo Brands, which owns the menswear brand Mufti and has operated since 1998, listed on December 27, 2023 without ever raising institutional funding. The four funded companies reached IPO in 7 to 17 years from founding, with Honasa Consumer's $126 million raise behind the fastest path at 7 years and Lenskart's $981 million raise behind the slowest at 17 years. Licious has stated its intention to reach profitability before listing, with an IPO planned for 2027–28.
India's D2C sector has experienced substantial acquisition activity with 105 D2C acquisitions recorded between 2021 and 2026 YTD. Among the most notable transactions, Hindustan Unilever's $350 million acquisition of skincare brand Minimalist in January 2025 represents the largest disclosed deal among the five most notable acquisitions. Wipro Consumer Care acquired Dermatouch for a disclosed $41 million on August 18, 2026, and USV India acquired Wellbeing Nutrition for a disclosed $175 million on February 12, 2026. Two earlier deals round out the group: Aditya Birla Group's TMRW acquired fashion brand Bewakoof in November 2022, and Reliance Retail acquired intimatewear brand Clovia in March 2022 at an undisclosed amount. Every acquirer in these transactions is an established consumer-facing conglomerate rather than a financial investor, including Hindustan Unilever and Wipro Consumer Care in FMCG, Reliance Retail and Aditya Birla Group's TMRW in diversified retail, and pharmaceutical major USV India. With Wipro Consumer Care and USV India both completing acquisitions in the first half of 2026, conglomerate interest in D2C brands looks set to continue rather than fade.
The funding breakdown across different stages reveals interesting trends in investor preferences and company maturity. According to Tracxn's analysis, seed and early-stage capital accounted for 70% of 2025's funding value, up from 38% in 2021, while early-stage funding alone rose 66% from its 2023 trough. Late-stage funding moved in the opposite direction, down 69% in value between 2022 and 2025, even as its round count returned to the 2021 level of 15. This shift indicates that capital is reaching a broader base of companies at earlier stages than it was five years ago, with the concentration inside the top-five group as steep as the leaderboard suggests. Seed activity accounted for the largest share of deal volume throughout the window, making up 70% to 77% of all rounds every year, and 2025 seed funding of $190 million was the highest of the window. The 2025 round count of 72 returned to its 2021 level, while late-stage funding moderated from $883 million across 22 rounds in 2022 to $271 million across 15 rounds in 2025.
